SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently a focal point of intense investor interest as the community awaits crucial Phase 3 data for its gene editing candidate and monitors the regulatory progress of its cardiac pipeline. With short interest levels remaining elevated, investors are actively debating the potential for a volatile move driven by upcoming clinical readouts and the possibility of a squeeze.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is seeing a surge in investor attention as the community anticipates news regarding potential Joint Development Agreements and commercial licensing deals tied to its Mears Silicon Technology, particularly within the Gate-All-Around and DRAM sectors. Traders are closely monitoring the stock's significant volume and price volatility, driven by speculation over partnerships with major semiconductor foundries and equipment manufacturers amid a broader focus on AI infrastructure.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is facing downward pressure following a series of insider share sales, which has sparked frustration among retail investors already concerned by the company's long-term capital efficiency and commercial ramp-up. Despite the negativity, the community remains divided between those calling for a strategic buyout or management change and long-term believers who are leveraging the dip to accumulate shares based on the company's extensive gene-editing pipeline and substantial cash position.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a massive surge in market interest, driven by speculation over potential partnerships with major hyperscalers and its critical role in AI optical interconnects. The community is actively discussing the stock's parabolic volume and momentum, with longs celebrating the potential for a sustained breakout while shorts remain under intense pressure.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is currently trending as traders aggressively reprice the stock following a significant earnings beat and raised guidance that highlights its growing role in AI-driven data center infrastructure. The community remains divided, with bulls pointing to fundamental momentum and institutional interest, while bears warn of a potential overvaluation and pump-and-dump mechanics after the recent parabolic price move.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is gaining momentum as investors eye upcoming industry events and potential integration news, with the community actively debating the project's utility versus broader market volatility. Enthusiasts are focusing on long-term growth and technical accumulation, while discussion remains divided between those expecting significant adoption and others expressing caution over price trends.

APE fuels culture. Backed by the best club in the world and hundreds of thousands of holders worldwide, it’s the token for digital and IRL communities, builders, creators, collectors, gamers, and beyond.  APE is the native gas token of ApeChain and is available across multiple ecosystems including Ethereum, Arbitrum, Solana and HyperLiquid.z  ApeCoin's mission is is to supercharge its ecosystem by supporting high-quality builders &amp; reinforcing 3 core pillars: ApeChain, Bored Ape Yacht Club, and Otherside.

ApeCoin

ApeCoin is seeing a surge in investor attention and high-volume volatility, fueled by the launch of ApeChain and the influx of new on-chain projects. The community remains divided, with some traders highlighting the token's aggressive, flow-driven momentum while others express frustration over long-term price performance and historical dilution concerns.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is experiencing heightened volatility and strong community interest following a strategic collaboration with NVIDIA and Los Alamos National Laboratory, which is fueling excitement around the company's role in powering AI infrastructure. While bullish investors point to these institutional partnerships and potential regulatory catalysts as long-term drivers, others remain cautious, citing the company's pre-revenue status and recent insider selling activity.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

iShares Semiconductor ETF is experiencing intense volatility and record-breaking volume as traders debate whether the sector's parabolic run represents an unsustainable bubble or a continued momentum-driven surge. Community sentiment is deeply divided, with many actively hedging against a potential blow-off top while others remain focused on the sector's long-term dominance in AI infrastructure.

Dumb SEND IT

The community is actively rallying around the new project Dumb SEND IT ($DSIT), driven by low-market-cap growth potential and promises of community airdrops from an active developer. Investors are discussing its momentum on Solana and encouraging others to buy and hold through the weekend as they push for a breakout past its initial resistance levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alphatec (NASDAQ:ATEC) Sets New 1-Year Low - Should You Sell?

Alphatec (NASDAQ:ATEC) Sets New 52-Week Low - Time to Sell...

ATEC to Report First Quarter 2026 Financial Results on May 5, 2026

Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2026 financial...

Alphatec (ATEC) Projected to Post Earnings on Thursday

Alphatec (NASDAQ:ATEC) will be releasing its Q1 2026 earnings after the market closes on Thursday, April 30. (View Earnings Report at...

Alphatec (NASDAQ:ATEC) Shares Down 7.5% - What's Next?

Alphatec (NASDAQ:ATEC) Trading Down 7.5% - What's Next...

Alphatec Holdings, Inc. (NASDAQ:ATEC) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Free Report) have been assigned an average rating of "Moderate Buy" from the twelve analysts that are currently covering the stock, MarketBeat...

Tudor Investment Corp ET AL Grows Position in Alphatec Holdings, Inc. $ATEC

Tudor Investment Corp ET AL boosted its stake in Alphatec Holdings, Inc. (NASDAQ:ATEC - Free Report) by 608.4% during the 3rd quarter, according to the company in its most recent filing with the...

Aberdeen Group plc Purchases 294,792 Shares of Alphatec Holdings, Inc. $ATEC

Aberdeen Group plc boosted its holdings in Alphatec Holdings, Inc. (NASDAQ:ATEC - Free Report) by 29.7% in the 4th quarter, according to the company in its most recent filing with the Securities and...

Alphatec CFO Sells $986K in Stock With Shares Up 9% This Past Year. Here's What Investors Should Know

Key PointsThe CFO of Alphatec Holdings reported selling 79,789 shares of the company on March 13, 2026, generating a transaction value of approximately $986,000...

Assenagon Asset Management S.A. Raises Position in Alphatec Holdings, Inc. $ATEC

Assenagon Asset Management S.A. grew its stake in Alphatec Holdings, Inc. (NASDAQ:ATEC - Free Report) by 30.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 978,343 shares of the medical techn...

Alphatec Holdings, Inc. (NASDAQ:ATEC) Receives Average Recommendation of "Moderate Buy" from Brokerages

Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Free Report) has received a consensus rating of "Moderate Buy" from the twelve analysts that are currently covering the firm, Marketbeat Ratings reports...

Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. The firm offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. It operates through the United States and International geographical segments. The company was founded on March 4, 2005, and is headquartered in Carlsbad, CA.

ATEC
Alphatec Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ATEC News

ATECAlphatec Holdings Inc